Can Your Period Affect Your Cholesterol Levels?

Cholesterol levels in premenopausal women shift measurably across the menstrual cycle, with total cholesterol and LDL (“bad”) cholesterol tending to peak in the first half of the cycle and drop in the second half. The swings are driven by rising and falling estrogen and progesterone, and while they are modest in absolute terms, they can be large enough to change whether a blood test flags you as having high cholesterol or not. The story gets more interesting once you factor in hormonal contraception, conditions like PCOS, and what happens when periods stop altogether.

How Cholesterol Moves Across a Normal Cycle

The overall pattern, confirmed across multiple studies, is that total cholesterol and LDL cholesterol are highest during the follicular phase (the stretch from menstruation through to ovulation) and lowest during the luteal phase (after ovulation, before your next period). HDL cholesterol, the protective kind, tends to peak right around ovulation and then drift downward. A review of the evidence in Clinical Lipidology summarized the trend this way: total cholesterol and LDL tend to be highest in the follicular phase and decline in the luteal phase, with HDL peaking near ovulation.¹

How big is the change? In a controlled-diet study where researchers eliminated food as a variable, LDL cholesterol in the midluteal phase was about 7% lower than in the early follicular phase.² Another study found that total cholesterol and LDL dropped significantly from the follicular to the luteal phase, while triglycerides and HDL shifted in the expected direction but did not reach statistical significance on their own.³ A separate dietary study observed a similar weekly decline in total and LDL cholesterol across the cycle, with HDL rising in the first half and falling in the second half, confirming the pattern even when diet was tightly controlled.⁴

Seven percent may sound small, but cholesterol categories have hard cutoffs. If your LDL is hovering near a treatment threshold, testing during the first week of your cycle could push the number above the line, while testing two weeks later might put you comfortably below it.

What Estrogen and Progesterone Actually Do to Lipids

Estrogen is the main player. It promotes the clearance of LDL from the bloodstream and encourages the liver to produce more HDL. A review of how sex hormones regulate liver lipid metabolism described estrogen’s role in influencing fatty acid, triglyceride, and cholesterol pathways, with downstream effects on cardiovascular risk.⁵ Because estrogen climbs steeply before ovulation and remains elevated (though somewhat lower) in the luteal phase, LDL clearance picks up in the second half of the cycle. That helps explain the mid-cycle LDL dip.

Progesterone’s contribution is more nuanced. It opposes some of estrogen’s triglyceride-raising effects by speeding up the clearance of certain fat-carrying particles. But progesterone also appears to suppress cholesterol synthesis itself, which may contribute to lower total cholesterol during the luteal phase when progesterone is at its peak.⁵

One enzyme that ties the hormones to lipid changes is hepatic lipase, which breaks down HDL particles. In women with normal progesterone levels, hepatic lipase activity drops during the luteal phase, likely because of the preceding estrogen surge at mid-cycle. That suppression allows HDL to stay higher for a while. Women with deficient luteal-phase progesterone did not show the same fluctuation in hepatic lipase, suggesting the cycle needs to be functioning normally for these lipid shifts to occur.⁶

Why the Timing of a Cholesterol Test Matters

This is where the cycle’s effect on cholesterol stops being a curiosity and starts having real consequences. A study published in Epidemiologic Reviews looked at what happens when you ignore cycle phase in cholesterol screening. The finding was striking: nearly twice as many women had cholesterol above the treatment threshold of 200 mg/dL during the follicular phase compared with the luteal phase (about 14% versus 8%), and only 3% had consistently elevated levels across all phases.⁷ That means a woman tested on day 5 of her cycle might be told she needs medication, while the same woman tested on day 21 might get an all-clear.

The European Heart Journal published results from a prospective study that concluded: even though the absolute variation in most women is modest, the moment of measurement can be clinically important for women with borderline-high lipids. The researchers recommended measuring lipids at a fixed point in the cycle for those women.⁸

In practice, almost no doctor asks where you are in your cycle before ordering a lipid panel. Standard guidelines do not account for it. If you are premenopausal and your total cholesterol or LDL comes back borderline high, it is worth asking whether retesting at a different point in your cycle would change the result before committing to treatment.

How Hormonal Contraceptives Change the Picture

Because the menstrual cycle’s effects on cholesterol are hormone-driven, anything that alters your hormonal environment changes the equation. Hormonal contraceptives are the most common example, and their effects depend heavily on the specific formulation.

Combined oral contraceptives (the pill with both estrogen and a progestin) have varied lipid effects. A large study in the New England Journal of Medicine found that combination pills did not raise total cholesterol overall, but they increased fasting triglycerides by anywhere from 13% to 75% depending on the formulation. LDL went down with some progestin types (desogestrel reduced it by about 14%) but the effect on HDL was all over the map: formulations with levonorgestrel lowered HDL by 5% to 16%, while those with desogestrel or low-dose norethindrone raised it by 10% to 12%.⁹

The balance between estrogen and progestin in the pill is the key variable. An earlier study found that formulations low in estrogen and high in progestin raised LDL by about 24% compared to non-users, while high-estrogen, low-progestin formulations raised HDL. The authors suggested that this estrogen-progestin balance might help explain the increased cardiovascular events seen in some pill users.¹⁰ A cohort study found that oral contraceptive users had roughly 29% higher odds of having abnormal total cholesterol compared to non-users, after adjusting for age, weight, and education.¹¹

Progestin-only methods tell a different story. A study tracking women on levonorgestrel implants and injectable medroxyprogesterone found no significant changes in metabolic parameters, including lipids, over a year of use.¹² Similarly, progestin-only pills containing desogestrel or levonorgestrel had minimal effects on lipid metabolism: LDL stayed flat, and total cholesterol and triglycerides dropped only marginally.¹³ If you are concerned about cholesterol and choosing a contraceptive, the progestin component matters most. Some progestins are lipid-neutral, while others push LDL up or HDL down. A conversation with your prescriber about which progestin is in a given formulation is worth having.

PCOS and Irregular Periods

Polycystic ovary syndrome is probably the most common condition where menstrual irregularity and abnormal cholesterol overlap, and the connection is not coincidental. Women with PCOS tend to have higher LDL and triglycerides and lower HDL than women without the condition. A meta-analysis found that triglycerides averaged about 26 mg/dL higher, LDL about 12 mg/dL higher, and HDL about 6 mg/dL lower in women with PCOS. Beyond the raw numbers, the quality of LDL particles also shifts: women with PCOS tend to carry more of the small, dense LDL particles that are more strongly linked to arterial plaque.¹⁴

The dyslipidemia in PCOS is tied to insulin resistance and excess androgens rather than to the simple estrogen-progesterone cycling described earlier. So the mechanism is different from the normal cycle fluctuations. But the practical takeaway is that irregular periods can themselves be a signal that your lipid profile deserves attention. If your cycles are consistently irregular, especially if other PCOS features are present, cholesterol screening becomes more important, not less.

When Ovulation Does Not Happen

You do not need a PCOS diagnosis for anovulation to affect your cholesterol. Some women with seemingly regular cycles occasionally fail to ovulate (so-called sporadic anovulatory cycles), and even those months carry a measurable lipid cost. A study comparing ovulatory and anovulatory cycles in the same women found that total cholesterol averaged about 4.6 mg/dL higher, and triglycerides about 6.4 mg/dL higher, during anovulatory months, after adjusting for age and weight.¹⁵

The likely explanation circles back to progesterone. When ovulation does not occur, the corpus luteum does not form, progesterone stays low, and the luteal-phase dip in cholesterol does not materialize. The cycle looks normal on the calendar, but hormonally it is incomplete, and the lipid pattern reflects that.

What Happens When Periods Stop

If the subtle hormonal shifts of a normal cycle move cholesterol a few percentage points, losing those hormones entirely has a much larger effect. Two distinct scenarios illustrate this: menopause and functional amenorrhea in younger women.

Menopause

The menopausal transition is associated with a substantial rise in cholesterol. A longitudinal study found that total cholesterol and LDL climbed by roughly 11% and 19%, respectively, across perimenopause.¹⁶ A 10-year study put the total cholesterol increase at about 19% during the eight years surrounding menopause, with only minor further change afterward.¹⁷ The driving force is the sustained loss of estrogen’s LDL-clearing, HDL-boosting effects. This is the same mechanism that operates during the menstrual cycle, just amplified and made permanent.

Hormone replacement therapy can partially reverse these changes, but the route of delivery matters. Oral estrogen has been shown to lower LDL and raise HDL within weeks, while transdermal (patch) estrogen has little effect on lipid levels.¹⁸ A study comparing the two routes directly confirmed that oral estrogen reduced total cholesterol and LDL and raised triglycerides and HDL, while the transdermal group showed little or no change.¹⁹ The difference exists because oral estrogen passes through the liver first, directly stimulating the production of HDL and the uptake of LDL, while transdermal estrogen enters the bloodstream and largely bypasses the liver’s lipid machinery.

Functional Amenorrhea in Younger Women

Periods can also stop in younger women who exercise heavily, eat too little, or are under extreme stress. This is called functional hypothalamic amenorrhea, and it creates a hormonal environment that in some ways mimics menopause: estrogen drops to very low levels. The lipid consequences are surprisingly similar. A systematic review and meta-analysis found that physically active women with secondary amenorrhea had significantly higher total cholesterol, triglycerides, LDL, and HDL compared with regularly cycling women.²⁰ That finding is counterintuitive, because these are often lean, highly active women who look healthy by every other measure.

A review in the Journal of Endocrinological Investigation highlighted that women with exercise-related amenorrhea present higher total cholesterol, LDL, and triglyceride levels than healthy controls.²¹ The proposed mechanism is that severe estrogen deficiency in these athletes increases cardiovascular risk in a way that parallels postmenopausal women.²² In other words, losing your period is not just an inconvenience or a sign of peak fitness. It is an early indicator that your body has lost a hormonal protection it normally relies on.

Blood Vessel Function Shifts Across the Cycle Too

Cholesterol numbers are one piece of the cardiovascular puzzle, but estrogen also acts directly on blood vessels. A study measuring how well the brachial artery dilates in response to increased blood flow found that during menstruation, when estrogen is at its lowest, blood vessel function in women was comparable to that of men. Once estrogen rose toward ovulation and into the luteal phase, the arteries dilated significantly more, roughly 60% to 70% better than during menstruation.²³ This means the cycle does not just move lipid numbers on a lab report. It also changes how well your arteries respond to the demands of blood flow, offering more protection during the high-estrogen phases and less during menstruation.

For women with functional amenorrhea, this vascular benefit disappears along with the hormonal cycling. The meta-analysis cited earlier also found reduced flow-mediated dilation in amenorrheic women, which aligns with the unfavorable lipid profiles these women carry.²⁰ The vascular and lipid effects reinforce each other, making the loss of normal cycling a double hit to cardiovascular protection.

Progesterone’s Evolutionary Balancing Act

There is an interesting evolutionary angle to why progesterone suppresses cholesterol. Both progesterone and cholesterol are essential for a successful pregnancy. Progesterone dials down the immune system enough to tolerate a genetically foreign embryo, while cholesterol is a building block for cell membranes and hormones the fetus needs. Yet progesterone actively reduces cholesterol production. Researchers have described this as a second-order adaptation: progesterone’s anti-cholesterol effect may be a trade-off the body accepts because the immune-calming benefits of high progesterone outweigh the cost of temporarily lower cholesterol availability. The result is the luteal-phase cholesterol dip that shows up on lab work, which is really a byproduct of the body preparing for the possibility of pregnancy every single cycle.